Jiankang Hu

Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia

Yan Zhang, Qiu-ping Xiang, Tian Wu, 2023, Bioorganic Chemistry.

Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity.

Yan Zhang, Tian Wu, Xiaoshan Chen, 2024, Journal of medicinal chemistry.